Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

The American Geriatrics Society (AGS) supports the recently announced decision from the Centers for Medicare and Medicaid Services (CMS) to require the collection of real-world information via a registry to study monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease.

11 Jul 2023

Whole genome sequencing shows promise for early diagnosis of genetic disorders in newborns, infants

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants.

11 Jul 2023

Study provides unprecedented insights into the complexity of large-scale neural networks

That experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University of Technology now shows how massive these effects really are.

11 Jul 2023

UVA researchers discover how 'hair cells' repair themselves

University of Virginia School of Medicine researchers have discovered how the cells that let us hear can repair themselves after being damaged.

10 Jul 2023

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses.

10 Jul 2023

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Research discusses the process of discovering anti-inflammatory and neuroprotective drugs from medicinal plants found in the Australian rainforest. It focuses on the pathways from the discovery of bioactive plants to the validation in an appropriate neuro-inflammatory mouse model, using some examples from their current research.

9 Jul 2023

New program offers hiking adventures for people with younger-onset Alzheimer's

Starting this July, people diagnosed with Alzheimer's before age 65 will have a new opportunity to connect with others while exploring the great outdoors through a program called SOAR. The name is an acronym for Shared Outdoor Adventures for Resilience.

7 Jul 2023

Quantum medicine: the way forward?

Study examines how quantum physics can contribute to medicine.

7 Jul 2023

Pennington Biomedical Research Center works to combat childhood obesity

One in five children have obesity in the U.S., and even more are considered overweight. Dr. Amanda Staiano, associate professor at Pennington Biomedical Research Center and director of the Pediatric Obesity and Health Behavior Laboratory, believes childhood obesity is at the top of the list for public health issues of this century because children with obesity are much more likely to develop heart disease, diabetes, asthma, sleep problems and other issues.

6 Jul 2023

FKBP5 deficiency linked to atrial fibrillation

Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver.

6 Jul 2023

Multiple discoveries open new paths for early prediction of Parkinson's disease trajectories

Hand tremors and slowed movements are two of the most widely recognized hallmarks of Parkinson's disease, and for many sufferers the first indication that something is amiss.

6 Jul 2023

Does a healthy diet protect against dementia and slow the pace of biological aging?

Study tested whether healthy diets slowed biological aging and, thus, dementia.

6 Jul 2023

Why the next big hope for Alzheimer’s might not help most Black patients

This week the FDA is expected to approve what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer's disease.

6 Jul 2023

Short sleep can diminish the cognitive benefits of physical activity

Regular physical activity may protect against cognitive decline as we get older, but this protective effect may be diminished for people who are not getting enough sleep, according to a new study by UCL researchers.

5 Jul 2023

Gum disease and tooth loss linked to brain shrinkage

Taking good care of your teeth may be linked to better brain health, according to a study published in the July 5, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Jul 2023

Fluctuating cholesterol and triglyceride levels may increase risk of Alzheimer's

Older people who have fluctuating levels of cholesterol and triglycerides may have a higher risk of Alzheimer's disease and related dementias compared to people who have steady levels, according to new research published in the July 5, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

5 Jul 2023

PET scan not effective in diagnosing chronic traumatic encephalopathy in former NFL players, study finds

A new study showed that positron emission tomography (PET) with the radiotracer (18F)-Flortaucipir (FTP) to detect hyperphosphorylated Tau (p-tau) may not be appropriate for diagnosing chronic traumatic encephalopathy (CTE) neuropathologic changes in former professional American-style football players.

5 Jul 2023

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Researchers present the mechanisms by which SARS-CoV-2 could infect the brain and affect memory.

5 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

EPFL scientists develop an innovative method for reconstructing Tau fibrils

EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer's disease and other neurodegenerative diseases.

4 Jul 2023

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

Whole genome sequencing shows promise for early diagnosis of genetic disorders in newborns, infants

Study provides unprecedented insights into the complexity of large-scale neural networks

UVA researchers discover how 'hair cells' repair themselves

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

New program offers hiking adventures for people with younger-onset Alzheimer's

Quantum medicine: the way forward?

Pennington Biomedical Research Center works to combat childhood obesity

FKBP5 deficiency linked to atrial fibrillation

Multiple discoveries open new paths for early prediction of Parkinson's disease trajectories

Does a healthy diet protect against dementia and slow the pace of biological aging?

Why the next big hope for Alzheimer’s might not help most Black patients

Short sleep can diminish the cognitive benefits of physical activity

Gum disease and tooth loss linked to brain shrinkage

Fluctuating cholesterol and triglyceride levels may increase risk of Alzheimer's

PET scan not effective in diagnosing chronic traumatic encephalopathy in former NFL players, study finds

Beyond the lungs: SARS-CoV-2's multi-organ impact revealed

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

EPFL scientists develop an innovative method for reconstructing Tau fibrils

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in